Wells Fargo Elevates GeneDx Price Target to $95 Amid Strong Analyst Confidence
GeneDx (NASDAQ:WGS) has recently experienced a significant boost in its financial outlook, as Wells Fargo & Company raised its price objective for the genomics company from $78.00…